Abe S - Search Results

1

Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis.

Hiura M, Abe S, Tabaru A, Shimajiri S, Hanami K, Saito K, Tanaka Y, Harada M. Hiura M, et al. Among authors: abe s. Hepatol Res. 2011 May;41(5):492-6. doi: 10.1111/j.1872-034X.2011.00793.x. Epub 2011 Mar 21. Hepatol Res. 2011. PMID: 21435128

2

Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma.

Narita R, Oto T, Mimura Y, Ono M, Abe S, Tabaru A, Yoshikawa I, Tanimoto A, Otsuki M. Narita R, et al. Among authors: abe s. J Gastroenterol. 2002 Jan;37(1):55-8. doi: 10.1007/s535-002-8134-0. J Gastroenterol. 2002. PMID: 11824802

3

High-dose interferon-alpha therapy lowers the levels of serum fibrogenesis markers over 5 years in chronic hepatitis C.

Abe S, Tabaru A, Ono M, Tai M, Narita R, Moriyama A, Otsuki M. Abe S, et al. Hepatol Res. 2003 Jan;25(1):22-31. doi: 10.1016/s1386-6346(02)00203-6. Hepatol Res. 2003. PMID: 12644035

4

Idiopathic thrombocytopenic purpura with acute hepatitis C viral infection.

Narita R, Asaumi H, Abe S, Nakamura H, Tabaru A, Yoshikawa I, Yamada S, Otsuki M. Narita R, et al. Among authors: abe s. J Gastroenterol Hepatol. 2003 Apr;18(4):462-3. doi: 10.1046/j.1440-1746.2003.02967.x. J Gastroenterol Hepatol. 2003. PMID: 12653900 No abstract available.

5

Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis C.

Abe S, Narita R, Hiura M, Jia DM, Tabaru A, Otsuki M. Abe S, et al. J Gastroenterol. 2004;39(3):247-54. doi: 10.1007/s00535-003-1286-5. J Gastroenterol. 2004. PMID: 15065002

6

Insulin resistance and insulin secretion in chronic hepatitis C virus infection.

Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Narita R, et al. Among authors: abe s. J Hepatol. 2004 Jul;41(1):132-8. doi: 10.1016/j.jhep.2004.03.020. J Hepatol. 2004. PMID: 15246219

7

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.

Tabaru A, Narita R, Hiura M, Abe S, Otsuki M. Tabaru A, et al. Among authors: abe s. Am J Gastroenterol. 2005 Apr;100(4):862-7. doi: 10.1111/j.1572-0241.2005.40826.x. Am J Gastroenterol. 2005. PMID: 15784033 Clinical Trial.

8

Effect of combination therapy with ribavirin and high-dose interferon-alpha2b for 24 weeks in chronic hepatitis C.

Abe S, Narita R, Oto T, Tabaru A, Otsuki M. Abe S, et al. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):308-12. doi: 10.1111/j.1440-1746.2006.04173.x. J Gastroenterol Hepatol. 2006. PMID: 16460492 Clinical Trial.

9

[Influence of job-related factors on the clinical course of chronic hepatitis].

Tabaru A, Matsuoka H, Maekawa S, Shimada M, Narita R, Abe S, Yamasaki M, Tashiro M, Taguchi M, Yamamoto M, Kihara Y, Kume K, Yoshikawa I, Nakamura H, Otsuki M. Tabaru A, et al. Among authors: abe s. Nihon Shokakibyo Gakkai Zasshi. 2007 Aug;104(8):1192-203. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17675821 Japanese.

10

Impact of steatosis on insulin secretion in chronic hepatitis C patients.

Narita R, Abe S, Tabaru A, Otsuki M. Narita R, et al. Among authors: abe s. Am J Gastroenterol. 2007 Oct;102(10):2173-80. doi: 10.1111/j.1572-0241.2007.01443.x. Epub 2006 Aug 4. Am J Gastroenterol. 2007. PMID: 17680843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,072 results

Search Page